Offer Or sold $879K of SMWB
Offer Or (Chief Executive Officer) sold 114,300 shares of SIMILARWEB LTD. (SMWB) at an average of $7.69 ($7.69–$8.37, $0.88M total) across 2 trades on 2026-09-24 under a Rule 10b5-1 trading plan.
SIMILARWEB LTD.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $SMWB in the last 7 days.
Offer Or (Chief Executive Officer) sold 114,300 shares of SIMILARWEB LTD. (SMWB) at an average of $7.69 ($7.69–$8.37, $0.88M total) across 2 trades on 2026-09-24 under a Rule 10b5-1 trading plan.
SimilarWeb Ltd (NYSE:SMWB) shares dropped 7% after naming Michael Akkerman as CEO, effective November 2, 2026. Akkerman succeeds founder Or Offer, who announced his departure in May 2026. The company assured no changes to strategy, operations, or financial outlook. Akkerman previously held roles at Cardlytics, Uber, and Pinterest.
Offer Or (Chief Executive Officer) sold 62,900 shares of SIMILARWEB LTD. (SMWB) at an average of $8.45 ($8.38–$8.54, $0.53M total) across 2 trades over 2026-09-22 to 2026-09-23 under a Rule 10b5-1 trading plan.
Recent SMWB coverage spans insider activity, market movers and financial news.
In the last 30 days, SMWB insiders filed 8 SEC Form 4 transactions — no purchases and 8 sales ($2.6M). The most active reporter was Offer Or, Chief Executive Officer, with 8 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
The insider sale reduces the CEO's stake but is pre‑arranged, likely limiting immediate price pressure.
The new CEO appointment triggered a sharp sell‑off, indicating market concern over leadership transition.
Potential short-term pressure on SMWB stock due to insider sell.
Potential short-term selling pressure; insider confidence may be questioned.
Insider sell may signal confidence concerns, could pressure SMWB price short-term.
AlphAI scores every news story that mentions SMWB with an AI model for sentiment and relevance, and aggregates insider trades from SIMILARWEB LTD.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Offer Or (Chief Executive Officer) sold 114,300 shares of SIMILARWEB LTD. (SMWB) at an average of $7.69 ($7.69–$8.37, $0.88M total) across 2 trades on 2026-09-24 under a Rule 10b5-1 trading plan.
1 min readSimilarWeb Ltd (NYSE:SMWB) shares dropped 7% after naming Michael Akkerman as CEO, effective November 2, 2026. Akkerman succeeds founder Or Offer, who announced his departure in May 2026. The company assured no changes to strategy, operations, or financial outlook. Akkerman previously held roles at Cardlytics, Uber, and Pinterest.
2 min readOffer Or (Chief Executive Officer) sold 62,900 shares of SIMILARWEB LTD. (SMWB) at an average of $8.45 ($8.38–$8.54, $0.53M total) across 2 trades over 2026-09-22 to 2026-09-23 under a Rule 10b5-1 trading plan.
1 min readOffer Or (Chief Executive Officer) sold 69,700 shares of SIMILARWEB LTD. (SMWB) at an average of $8.32 ($8.25–$8.40, $0.58M total) across 2 trades over 2026-09-18 to 2026-09-21 under a Rule 10b5-1 trading plan.
1 min readOffer Or (Chief Executive Officer) sold 76,119 shares of SIMILARWEB LTD. (SMWB) at an average of $8.38 ($8.35–$8.40, $0.64M total) across 2 trades over 2026-09-16 to 2026-09-17 under a Rule 10b5-1 trading plan.
1 min readAnalysts made several rating changes: Wolfe upgraded Paychex (PAYX) citing stable employment trends. UBS upgraded Union Pacific (UNP) to Buy with a $339 price target, expecting strong 2027 volume growth. Needham upgraded Rocket Pharmaceuticals (RCKT) to Buy with a $9 target after FDA reaffirmed study design. JPMorgan upgraded Credicorp (BAP) to Overweight with a $482 target, seeing strong EPS growth. Morgan Stanley downgraded Expedia (EXPE) to Underweight with a $235 target, citing weaker assets
3 min readFutures rise ahead of the Fed's expected 25bp rate hike, the first since 2023. Intel (INTC) shares jump 3% on reports of talks with SK Hynix for US memory chip production. JB Hunt (JBHT) falls 11% due to rising costs and an earnings warning. Alvotech (ALVO) rises 7% after a Barclays upgrade. The Fed's decision and economic data releases are key focuses for investors.
3 min readAnalysts upgraded several companies: Needham upgraded Similarweb (SMWB) to Buy with a $11 target, Wolfe Research upgraded Paychex (PAYX) to Peer Perform, Needham upgraded Rocket Pharmaceuticals (RCKT) to Buy with a $9 target, UBS upgraded Union Pacific (UNP) to Buy with a $339 target, and Barclays upgraded Alvotech (ALVO) to Overweight with a $8 target.
2 min readWall Street analysts upgraded Credicorp (BAP) to Overweight, Paychex (PAYX) to Peer Perform, Rocket Pharmaceuticals (RCKT) to Buy, Similarweb (SMWB) to Buy, and Union Pacific (UNP) to Buy. Downgrades include Expedia (EXPE) to Underweight, Grupo Aval (AVAL) to Underweight, Hartford Financial (HIG) to Neutral, Meritage Homes (MTH) to Hold, and Nubank (NU) to Market Perform. Initiations: Airbnb (ABNB) with Equal Weight, Booking Holdings (BKNG) with Overweight, Dutch Bros (BROS) with Buy, Five9 (FIV
2 min readNeedham upgraded Similarweb (SMWB) to Buy from Hold, citing strong sales potential. Analyst Scott Berg met with Similarweb's CFO and IR VP, leading to the upgrade.
1 min read